Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years due to Washington's demand for confidential information.
The decision became public following a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government spokesperson later explained that the United States was requesting genetic material for scientific study and commercial gain but was unwilling to share the benefits from future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for continued dialogue to find a agreement suitable to all parties so the nation's vital HIV treatment initiative can proceed.
Broader Background
This development follows a similar situation in neighbouring Kenya, where a court halted a related deal with the US after legal challenges were raised about the security of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance transparency and responsibility.
As per reports, Sixteen nations in Africa have to date agreed to these new health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment through US-supported initiatives," the Ambassador said.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to provide its genetic material and health information indefinitely, with no equivalent assurance of benefiting from any medical innovations – like new medicines or tests – that could be developed from that shared data," his statement read.
"Put simply, our nation would supply the basic resources for scientific discovery with no certainty that the end products would be accessible to our citizens should a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the global health body and its push of one-on-one health agreements were undermining systems previously set up through the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage future global health emergencies.
"This framework is intended to ensure that when a country provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome further discussions with our US partners on how future co-operation could be designed in a manner that respects the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that talks need to persist considering a large portion of the nation's Aids initiatives relied on foreign aid.
"If technical issues exist, including those relating to information security or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," it commented.
The situation highlights the ongoing tensions between accepting vital foreign assistance and safeguarding a country's data in an ever more data-driven world.